welcome to

At Sanodyne Therapeutics, we are dedicated to bringing hope and relief to patients suffering from peripheral neuropathy and neuropathic pain.
By leveraging cutting-edge science and our deep experience in pain management, We are committed to developing innovative therapies that restore comfort and improve quality of life.
Healing lives, relieving pain. Sanodyne Therapeutics, Inc.

PIPELINE

SNT-001

Our lead product, SNT-001, is an orally available small molecule compound underdeveloped for peripheral neuropathy and neuropathic pain. It is a drug with a unique mechanism of action and holds the potential to be a fundamental therapeutic agent for pain. It has a unique mechanism of action and holds the potential to be a disease-modifying agent for pain.

FEATURES

01

Orally available small molecule

02

Targeting peripheral neuropathy (e.g. CIPN, PHN, DN); Global market >$7B

03

Phase 2 ready, high safety/tolerability and good PK confirmed in a Phase 1 study

04

First-in-class, disease modifying potential

Healing lives, relieving pain. Sanodyne Therapeutics, Inc.
Healing lives, relieving pain. Sanodyne Therapeutics, Inc.

NEWS

read more
CONTACT
Healing Lives, Relieving Pain.
Sanodyne Therapeutics, Inc.
7th Floor, Nihonbashi Muromachi Mitsui Tower, 3-2-1 Muromachi Nihonbashi, Chuo-ku, Tokyo 103-0022, Japan
Healing lives, relieving pain. Sanodyne Therapeutics, Inc.